9. Perioperative care Flashcards
Postoperative risks
1) Bleeding (1-5%)
2) Arrhythmia (1-4%)
3) Wound infection (0,2-11%)
4) Pneumonia (0,1-7%)
5) Thromboembolism (0,1-5%)
6) MI (0,1-4%)
7) Stroke (0,1-4%)
Perioperative timeline
1) Assessment, prepping
2) OR
3) Postoperative care
Perioperative risks (complication)
1) Death (0-0,4%)
2) Brain damage (0,01-0,1%)
3) Nerve damage (0,01-1%)
4) Permanent dysfunction (0-10%)
5) Awareness (0,1-0,4%)
Influencing factors in perioperative risk
1) Age
2) Comorbidities
3) Surgery type
4) Anesthesia method
Preoperative risk assessment: person specific risks
- Medical history, physical assessment, lab
- ASA grade (likelihood for mortality)
- Intubation difficulty
- Risk of bleeding/thromboembolism
- Chronic illness
Mallampati classification
Evaluation of the palate and throat prior to intubation
Difficult airway algorhythm
1) Direct laryngoscopy -> tracheal intubation
2) If failed intubation: ILMA or LMA
3) Failed oxygenation: Revert to facemask -> oxygenation and ventilate
4) Failed oxygenation: LMA
5) Increasing hypoxemia: do cannula cricothyroidotomy or surgical cricothyroidotomy
Assessment of PO risk: Obesity
- Perioperative risk increased (ASAII)
- Intubation difficulty, CVS, resp comp inc., infection
- BUT! Mortality doesnt increase (obesity paradox)
Assessment of PO risk: Malnutrition
- Infections
- Dec. wound healing
- Pressure sores
Assessment of PO risk: Smoking
- CVS, resp comp inc.,
- Impaired wound healing, infections more common
- Mortality inc
- Cessation right before surgery might worsen outcome (stop >2months prior)
Preop prep.: Premedication
1) Chronic therapy adjustment
2) Anxiolysis - CVS risk reduc.
3) Preventive pain management - CVS risk reduc., postop compl. reduc.
4) Antacids - aspiration risk reduction
5) Thromboprophylaxis
6) Fasting
Included in chronic therapy adjustment
1) Anti-HTN
2) Antidiabetics - change to contollable drug (insulin)
3) Antiepileptics - withdrawal seizure
4) Hormone supp. - Preset therapy
5) Psychogenic drugs - withdrawal vs. sedative effect
Mortality rate in intraop. transfusion
80% in 10 year
Antiplatelet therapy adjustments
1) Low bleeding risk -> double APT
2) Med. bleeding risk, low/medium cardiac risk -> continue ASA, stop clopidogrel (5 days)
3) Med. bleeding risk, high CVS risk, high stent thrombosis risk -> double APT is possible
4) High bleeding risk, low CVS risk -> continue ASA if possible
5) High bleeding risk, medium/high CVS risk, high stent thrombosis risk -> iv glycoprotein, IIb/IIIa inhibitor?
Thromboprophylaxis in orthopedic surgery
Mechanical (IPC) and long term pharmacological LMWH (10-14), 35 days